Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


08.04.2019

1 Dig Dis Sci
1 Enferm Infecc Microbiol Clin
1 Gastroenterology
4 Hepatology
1 J Hepatol
2 J Med Virol
2 N Engl J Med
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Dig Dis Sci

  1. AHMAD J, Reddy KR, Tillmann HL, Hayashi PH, et al
    Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug-Induced Liver Injury.
    Dig Dis Sci. 2019 Mar 29. pii: 10.1007/s10620-019-05591.
    PubMed     Text format     Abstract available


    Enferm Infecc Microbiol Clin

  2. CRESPO J, Lazaro de Mercado P, Blasco Bravo AJ, Aguilera Guirao A, et al
    Diagnosis of hepatitis C virus infection in Spain: An opportunity to improve.
    Enferm Infecc Microbiol Clin. 2019;37:231-238.
    PubMed     Text format     Abstract available


    Gastroenterology

  3. THABUT D, Bureau C, Layese R, Bourcier V, et al
    Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients with Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
    Gastroenterology. 2019 Feb 12. pii: S0016-5085(18)35303.
    PubMed     Text format     Abstract available


    Hepatology

  4. JAIN MK, Rich NE, Ahn C, Turner BJ, et al
    Evaluation of a multifaceted intervention to reduce health disparities in hepatitis C screening: a pre-post analysis.
    Hepatology. 2019 Apr 4. doi: 10.1002/hep.30638.
    PubMed     Text format     Abstract available

  5. BAKR O, Gelberg L, Seragaki S, Youn S, et al
    Treating Hepatitis C in the Homeless at the Greater Los Angeles Veterans Affairs.
    Hepatology. 2019 Apr 4. doi: 10.1002/hep.30643.
    PubMed     Text format     Abstract available

  6. HOFMEISTER MG, Edlin BR, Rosenberg ES, Rosenthal EM, et al
    Reply to HCV prevalence estimates among incarcerated persons (Letter to the Editor regarding HEP-18-1268.R1).
    Hepatology. 2019 Apr 4. doi: 10.1002/hep.30635.
    PubMed     Text format     Abstract available

  7. SPAULDING AC, Graham CS, Akiyama MJ, Chhatwal J, et al
    HCV prevalence estimates among incarcerated persons.
    Hepatology. 2019 Apr 2. doi: 10.1002/hep.30636.
    PubMed     Text format     Abstract available


    J Hepatol

  8. UMUTESI G, Shumbusho F, Kateera F, Serumondo J, et al
    Rwanda launches a 5-year national hepatitis C elimination plan: A landmark in sub-Saharan Africa.
    J Hepatol. 2019 Apr 1. pii: S0168-8278(19)30179.
    PubMed     Text format    


    J Med Virol

  9. EL KASSAS M, Alboraie M, Omar H, El Latif YA, et al
    High success rates for the use of ombitasvir/paritaprevir/ritonavir containing regimens in treatment of naive and experienced chronic hepatitis C genotype 4: Real world results.
    J Med Virol. 2019 Apr 5. doi: 10.1002/jmv.25478.
    PubMed     Text format     Abstract available

  10. ZAYED SA, Zahran NM, Khorshied MM, Abdel-Aziz AO, et al
    Genetic variations in death receptor domain 4 (DR4) gene and the susceptibility to hepatitis C related hepatocellular carcinoma.
    J Med Virol. 2019 Apr 4. doi: 10.1002/jmv.25476.
    PubMed     Text format     Abstract available


    N Engl J Med

  11. BLUMBERG EA
    Organs from Hepatitis C Virus-Positive Donors.
    N Engl J Med. 2019 Apr 3. doi: 10.1056/NEJMe1901957.
    PubMed     Text format    

  12. WOOLLEY AE, Singh SK, Goldberg HJ, Mallidi HR, et al
    Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
    N Engl J Med. 2019 Apr 3. doi: 10.1056/NEJMoa1812406.
    PubMed     Text format     Abstract available


    PLoS One

  13. BUGGISCH P, Wursthorn K, Stoehr A, Atanasov PK, et al
    Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany.
    PLoS One. 2019;14:e0214795.
    PubMed     Text format     Abstract available

  14. AHSAN A, Khan AZ, Javed H, Mirza S, et al
    Estimation of hepatitis C prevalence in the Punjab province of Pakistan: A retrospective study on general population.
    PLoS One. 2019;14:e0214435.
    PubMed     Text format     Abstract available

  15. LEE YC, Hu TH, Hung CH, Lu SN, et al
    The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals.
    PLoS One. 2019;14:e0214323.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: